These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 9455823)
21. Ascites Index - a novel technique to evaluate ascites in ovarian hyperstimulation syndrome: a concept-proof study. Szkodziak PR; Czuczwar P; Wrona W; Paszkowski T; Szkodziak F; Woźniak S Ginekol Pol; 2018; 89(4):182-8. PubMed ID: 29781072 [TBL] [Abstract][Full Text] [Related]
22. Establishing an indwelling peritoneal catheter as a standard procedure for hospitalized patients with ascites: Retrospective data on feasibility, effectiveness and safety. Stratmann K; Fitting D; Zeuzem S; Bojunga J; Trebicka J; Friedrich-Rust M; Dultz G United European Gastroenterol J; 2019 Jun; 7(5):673-681. PubMed ID: 31210945 [TBL] [Abstract][Full Text] [Related]
23. Continuous peritoneal drainage of large-volume ascites. Van Thiel DH; Moore CM; Garcia M; George M; Nadir A Dig Dis Sci; 2011 Sep; 56(9):2723-7. PubMed ID: 21735084 [TBL] [Abstract][Full Text] [Related]
24. Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment. Binder H; Dittrich R; Einhaust F; Krieg J; Müller A; Strauss R; Beckmann MW; Cupisti S Int J Fertil Womens Med; 2007; 52(2-3):69-81. PubMed ID: 18320864 [TBL] [Abstract][Full Text] [Related]
25. Indwelling catheters for the management of malignant ascites. Lee A; Lau TN; Yeong KY Support Care Cancer; 2000 Nov; 8(6):493-9. PubMed ID: 11094995 [TBL] [Abstract][Full Text] [Related]
28. A severe case of ovarian hyperstimulation syndrome with liver dysfunction and malnutrition. Davis AJ; Pandher GK; Masson GM; Sheron N Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):779-82. PubMed ID: 12169989 [TBL] [Abstract][Full Text] [Related]
29. A severe case of ovarian hyperstimulation syndrome: 65 liters of ascites aspirated in an on-going IVF-ET twin pregnancy. Bar-Hava I; Orvieto R; Dicker D; Dekel A; Peley D; Ben-Rafael Z Gynecol Endocrinol; 1995 Dec; 9(4):295-8. PubMed ID: 8629457 [TBL] [Abstract][Full Text] [Related]
30. [Update on ovarian hyperstimulation syndrome]. Delbaere A; Rodesch C; Englert Y Rev Med Brux; 1995 Nov; 16(5):354-60. PubMed ID: 7501911 [TBL] [Abstract][Full Text] [Related]
31. Predictors of Paracentesis in Women with Severe Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study. Nouri K; Ott J; Lenart C; Walch K; Promberger R; Tempfer CB Gynecol Obstet Invest; 2016; 81(6):504-511. PubMed ID: 27399220 [TBL] [Abstract][Full Text] [Related]
32. Treatment of ovarian hyperstimulation syndrome: the physiologic basis for a modified approach. Thaler I; Yoffe N; Kaftory JK; Brandes JM Fertil Steril; 1981 Jul; 36(1):110-3. PubMed ID: 6788611 [TBL] [Abstract][Full Text] [Related]
33. Spontaneous severe ovarian hyperstimulation syndrome in successive pregnancies with successful outcomes. Lovgren TR; Tomich PG; Smith CV; Berg TG; Maclin V Obstet Gynecol; 2009 Feb; 113(2 Pt 2):493-495. PubMed ID: 19155932 [TBL] [Abstract][Full Text] [Related]
34. Postparacentesis bilateral massive vulvar edema in a patient with severe ovarian hyperstimulation syndrome. Vavilis D; Tzitzimikas S; Agorastos T; Loufopoulos A; Tsalikis T; Bontis JN Fertil Steril; 2002 Apr; 77(4):841-3. PubMed ID: 11937145 [TBL] [Abstract][Full Text] [Related]
35. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Chen CD; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS Fertil Steril; 1999 Aug; 72(2):286-92. PubMed ID: 10438997 [TBL] [Abstract][Full Text] [Related]
36. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis. Smith LP; Hacker MR; Alper MM Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762 [TBL] [Abstract][Full Text] [Related]
37. Dynamic changes of the immunoglobulins in patients with severe ovarian hyperstimulation syndrome: efficacy of a novel treatment using peritoneo-venous shunt. Takamizawa S; Shibahara H; Taneichi A; Obara H; Fujiwara H; Ogawa S; Koike T; Idei S; Sato I Am J Reprod Immunol; 2002 Jan; 47(1):25-30. PubMed ID: 11883746 [TBL] [Abstract][Full Text] [Related]
38. Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome. Lainas GT; Lainas TG; Venetis CA; Sfontouris IA; Zorzovilis IZ; Alexopoulou E; Tarlatzis BC; Kolibianakis EM Ultrasound Obstet Gynecol; 2018 Jan; 51(1):126-133. PubMed ID: 29105961 [TBL] [Abstract][Full Text] [Related]
39. Ovarian hyperstimulation syndrome: distinction between local and systemic disease. Cobellis L; Pecori E; Stradella L; De Lucia E; Messalli EM; Cobellis G Gynecol Endocrinol; 2003 Apr; 17(2):95-9. PubMed ID: 12737669 [TBL] [Abstract][Full Text] [Related]
40. Successful outcome of severe ovarian hyperstimulation syndrome (OHSS) with 27 liters of ascitic fluid removed by paracentesis. Grochowski D; Sola E; Kulikowski M; Kuczyński W; Wołczyński S; Szamatowicz M J Assist Reprod Genet; 1995 Jul; 12(6):394-6. PubMed ID: 8589562 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]